About Boston Heart Diagnostics
Boston Heart Diagnostics is a Healthcare company based in Framingham (United States) founded in 2007 by Bela Asztalos and Ernst Schaefer, and was acquired by Eurofins Scientific in December 2014. Diagnostics for personalized cardiovascular disease management are developed. Boston Heart Diagnostics has raised $10.34 million across 2 funding rounds from investors including Eurofins Scientific and Bain Capital Ventures. Its website bostonheartdiagnostics.com draws about 18 thousand monthly visits. Boston Heart Diagnostics offers products and services including CVMap, Polygenic Risk Map, LipoMap, Dried Blood Spot Tests, and Boston Heart Lifestyle Program. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, In-Vitro Diagnostics and Diversified. Its legal entity is Boston Heart Diagnostics Corporation. Its competitors include SpectraWAVE, Proxim Diagnostics and Prevencio; 3 of its 3 listed competitors have raised funding.
Company details
Founded in 2007 and based in Framingham, United States, Boston Heart Diagnostics operates in the healthcare sector, focusing on cardiovascular diagnostics. Proprietary lipid testing, advanced analytical tools, therapy guidelines, and patient support services are provided to physicians, patients, and pharmaceutical companies. These offerings facilitate disease management through integrated diagnostic solutions.
- Headquarters Framingham, United States
- Founders Bela Asztalos, Ernst Schaefer
- Stage Acquired
- SectorsHealthcare
- Website bostonheartdiagnostics.com
- Social LinkedIn X Facebook Instagram
- Acquired by Eurofins Scientific (Dec 2014)
- Legal Name Boston Heart Diagnostics Corporation
- Total Equity Funding$10.34M (USD)
in 2 rounds
- Latest Funding Round$10.05M (USD), Series C
Aug 2010
- InvestorsEurofins Scientific
& 1 more
- Acquired byEurofins Scientific
(Dec 2014)
Products & Services of Boston Heart Diagnostics
Boston Heart Diagnostics offers a comprehensive portfolio of products and services, including CVMap, Polygenic Risk Map, LipoMap, Dried Blood Spot Tests, and Boston Heart Lifestyle Program.
Assesses cardiovascular risk with advanced markers.
Evaluates genetic risks for complex diseases using scores.
Provides comprehensive analysis of lipid metabolism.
Offers convenient fingertip blood tests as an alternative to draws.
Delivers tailored lifestyle management for heart health.
Funding Insights of Boston Heart Diagnostics
Boston Heart Diagnostics has successfully raised a total of $10.34M across 2 strategic funding rounds. The most recent funding activity was a Series C round of $10.05 million completed in August 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $10.34M
- Total Rounds 2
- Last Round Series C — $10.05M
- First Round $286,000
(Mar 2009)
- Investors Count 1
All 2 funding rounds of Boston Heart Diagnostics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2010 | $10.05M | Series C | – | Bain Capital Ventures | – |
| Mar 2009 | $286,000 | Seed | – | – | – |
2 investors in total: 2 institutional.
Investors in Boston Heart Diagnostics
Boston Heart Diagnostics has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Eurofins Scientific and Bain Capital Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital fund focused on investing in multiple sectors | baincapitalventures.com | Boston, United States | ||
Laboratory testing and contract research services are provided globally. | 1987 | eurofins.com | Luxembourg, Luxembourg |
Investor details for Boston Heart Diagnostics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Boston Heart Diagnostics
33 people are tracked at Boston Heart Diagnostics (8 in leadership, 25 in team).
| Name | Role | Group |
|---|---|---|
Bela Asztalos | Co-Founder & CSO | Leadership |
Ernst Schaefer | Founder | Leadership |
Marianna Fernandes | Director Laboratory Operations | Leadership |
Ernst J Schaefer | Chief Medical Officer & Laboratory Director | Leadership |
Hugh Watson | Senior Vice President | Leadership |
Scott Madel | President | Leadership |
Kathleen McGuire | Vice President Operations | Leadership |
Tammy Grinnell | Director Customer Solutions | Leadership |
Maxine Lang, MT ASCP | Core Lab Manager | Team |
Annette McClain | Manager, Front End Operations | Team |
Alycia Rafter, MS | Senior Sales Support/Data Governance Specialist II | Team |
Susan Dietz | Medical Science Liaison | Team |
Jen Hughes | Medical Laboratory Scientist | Team |
Joan Monaco | Field Operations Manager | Team |
Haley Collentro, MLS (ASCP) | Medical Laboratory Scientist | Team |
Elizabeth Lucia | Client Contracting and AR Specialist | Team |
Bryan McCusty | HDL Map Laboratory Supervisor | Team |
Anne Foley, MT(ASCP) | Medical Technologist ASCP Automated Chemistry Department | Team |
Fransous Martinez | Customer Care Coordinator | Team |
Shannon Hache | Manager, Pre-analytics Department | Team |
13 more people are available in the full profile.
Complete people profiles for Boston Heart Diagnostics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Boston Heart Diagnostics
4 dated milestones of Boston Heart Diagnostics across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Boston Heart Diagnostics is founded.
- Funding First funding round of $286K.
- Funding Latest funding round, Series C, of $10.0M.
- Exit Acquired by Eurofins Scientific.
Competitors of Boston Heart Diagnostics
Boston Heart Diagnostics has 3 listed competitors in our database, 3 of them funded. They include SpectraWAVE, Proxim Diagnostics and Prevencio.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| spectrawave.com | 2012 | Waltham, United States | $79.88M | 36 | Photonic imaging diagnostics for cardiovascular disease treatment are provided. | |
| proximdx.com | 2010 | Sunnyvale, United States | $22.9M | Handheld immunodiagnostic devices for cardiac vascular diseases are developed. | ||
| prevenciomed.com | 2006 | Kirkland, United States | $5.68M | Protein-based diagnostics and prognostics for cardiovascular diseases are developed. |
Detailed competitors of Boston Heart Diagnostics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Boston Heart Diagnostics
The website of Boston Heart Diagnostics (bostonheartdiagnostics.com) receives about 18.2K visits a month.
- Monthly visits18.2K
▲ 18.5% vs previous month
Websites whose visitors overlap most with Boston Heart Diagnostics. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
pace-cme.org | pace-cme.org | 100% | #2,199,869 | – | |
| bioanalyt.com | 87% | 4.8K | #3,879,791 | View details | |
| biosite.com | 87% | View details | |||
| focusdx.com | 87% | View details | |||
| savyondiagnostics.com | 86% | #6,468,038 | View details | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 15 similar websites and full traffic analytics for Boston Heart Diagnostics
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 15 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Cardiac and Vascular Disorders
3 companies that operate in the same segment as Boston Heart Diagnostics (Cardiac and Vascular Disorders) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Gene-editing therapies for coronary artery disease are developed. | 2018 | Cambridge, Massachusetts, United States | USD 215.5 M | 255 | ||
Cardiac monitoring devices and applications are provided for heart health. | 2010 | Mountain View, California, United States | USD 114.38 M | USD 6.18 M | 67 | |
Therapies for lowering low-density lipoprotein cholesterol levels are developed. | 1998 | Ann Arbor, Michigan, United States | USD 129.7 M | USD 332.31 M | 304 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Boston Heart Diagnostics
Complete news archive for Boston Heart Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Boston Heart Diagnostics
Boston Heart Diagnostics was founded in 2007 and raised its 1st funding round 2 years after it was founded.
Boston Heart Diagnostics is headquartered in Framingham, United States. It is registered at Framingham, Massachusetts, United States.
Boston Heart Diagnostics is a funded company, having raised a total of $10.34M across 2 funding rounds to date. The company's 1st funding round was a Seed of $286K, raised on Mar 2009.
Founded in 2007 and based in Framingham, United States, Boston Heart Diagnostics operates in the healthcare sector, focusing on cardiovascular diagnostics. Proprietary lipid testing, advanced analytical tools, therapy guidelines, and patient support services are provided to physicians, patients, and pharmaceutical companies. These offerings facilitate disease management through integrated diagnostic solutions.
Boston Heart Diagnostics's top competitors include SpectraWAVE, Prevencio and Proxim Diagnostics.
Boston Heart Diagnostics offers CVMap, Polygenic Risk Map, LipoMap, Dried Blood Spot Tests, and Boston Heart Lifestyle Program.
Boston Heart Diagnostics has 2 investors. Key investors include Eurofins Scientific, and Bain Capital Ventures.
Boston Heart Diagnostics operates through Boston Heart Diagnostics Corporation.
Yes. Boston Heart Diagnostics was acquired by Eurofins Scientific in December 2014.